LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹28 Cr | ₹34 Cr | ₹36 Cr | ₹42 Cr | ₹38 Cr |
What is the latest Total Non-Current Liabilities ratio of LACTOSE (INDIA) ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹28 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹36 Cr |
Mar2021 | ₹42 Cr |
Mar2020 | ₹38 Cr |
How is Total Non-Current Liabilities of LACTOSE (INDIA) Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹28 Cr | -17.57 | |
Mar2023 | ₹34 Cr | -4.90 | |
Mar2022 | ₹36 Cr | -13.46 | |
Mar2021 | ₹42 Cr | 8.67 | |
Mar2020 | ₹38 Cr | - |
Compare Total Non-Current Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹126.4 Cr | 2.8% | 1.5% | -43% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,187.0 Cr | 0.6% | -2.4% | -7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,282.0 Cr | -0.3% | -7.6% | 23% | Stock Analytics | |
CIPLA | ₹128,619.0 Cr | 1.8% | 8.1% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,712.0 Cr | 0.9% | 3.7% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,577.0 Cr | 1% | 2.4% | -9.6% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | 2.8% |
1.5% |
-43% |
SENSEX | 0.9% |
-1.1% |
0.6% |
You may also like the below Video Courses